Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165
about
MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathwaypH regulates vascular endothelial growth factor binding to fibronectin: a mechanism for control of extracellular matrix storage and releaseExtracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.Glycoconjugates and related molecules in human vascular endothelial cellsDengue Virus Replicon Expressing the Nonstructural Proteins Suffices To Enhance Membrane Expression of HLA Class I and Inhibit Lysis by Human NK CellsADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165A heparan sulfate-facilitated and raft-dependent macropinocytosis of eosinophil cationic proteinCell-surface heparan sulfate proteoglycans potentiate chordin antagonism of bone morphogenetic protein signaling and are necessary for cellular uptake of chordinVEGFA-VEGFR2 Signaling PathwaySystems biology of vascular endothelial growth factorsSoluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells.Altered gene expression in murine placentas in an infection-induced intrauterine growth restriction model: a microarray analysis.The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease.Potential use of non-classical pathways for the transport of macromolecular drugs.Differential effects of Heparitinase I and Heparitinase III on endothelial tube formation in vitro.Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors.Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arenaHeparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability.Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases.Role of VEGF in kidney development, microvascular maintenance and pathophysiology of renal disease.Acquisition of anoikis resistance up-regulates syndecan-4 expression in endothelial cells.Perlecan and tumor angiogenesis.A KrasG12D-driven genetic mouse model of pancreatic cancer requires glypican-1 for efficient proliferation and angiogenesisSpatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesisGlypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells.Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognitionExtracellular angiogenic growth factor interactions: an angiogenesis interactome survey.Proteoglycans and their roles in brain cancer.Syndecan-1: a dynamic regulator of the myeloma microenvironment.Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma.Exosomal microRNA Biomarkers: Emerging Frontiers in Colorectal and Other Human Cancers.Redox signals in wound healingAutoregulation of glypican-1 by intronic microRNA-149 fine tunes the angiogenic response to FGF2 in human endothelial cellsSecretion of VEGF-165 has unique characteristics, including shedding from the plasma membrane.Recombinant production of proteoglycans and their bioactive domains.Heparan sulfate-protein binding specificity.Heparan sulfate in the regulation of neural differentiation and glioma development.VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase.The roles of ADAMTS in angiogenesis and cancer.A novel function of syndecan-2, suppression of matrix metalloproteinase-2 activation, which causes suppression of metastasis.
P2860
Q24294441-E098FA10-34FA-42AE-945D-E389497167FAQ24298247-551BF7F3-6C6A-4634-AA3F-16268E856758Q27000351-B22CF7F9-62A1-4A2D-A3F8-04675D52898BQ27008374-A85D4BBC-80EE-4096-A1B8-A33ED2BA5EA1Q27486580-2334780E-FFBB-4531-A7CA-15E98AE2D805Q28201376-B0CFDEB3-4552-48B0-AA90-225B760C68C0Q28253785-00220C27-3DA2-4372-A407-672D9AD471A0Q28512603-4C59B5C2-393F-468C-B9D6-44B7134A2F2BQ30225525-5FD89A55-C6E6-4B9A-B055-A17DCA3C9F92Q30438979-0CA2BA15-5E33-4F3E-8C1F-4DD59A3A51CFQ33737131-D6D6C3C4-2476-4770-96A7-FF174E3589F8Q33997325-07DADCBC-B777-41D5-A525-8655843ED6F8Q34022649-392C11AF-6468-4F89-AC27-46FAE1CBA0B2Q34075054-C0FF65B8-E0AB-4467-845C-541891C24C58Q34076045-C9C04E93-05A3-497B-9217-24DD2C2D002BQ34114308-E78954F3-56A6-4E59-B2E3-051F8D39C6ACQ34328750-87C2F363-E4C4-4476-9351-EFFA62A1167BQ34452740-FC7AF2C1-30F4-477C-9D6E-98B0414F771FQ34835409-BE985E96-A014-474C-AA48-9EF02A966BF8Q35181953-01C155EB-26ED-455C-9265-234604C4DF49Q35535743-AEBE3D53-C67A-4E9D-96A8-6EA98F1B9DA8Q35562693-356E01AD-7CAA-45EC-B8D9-A6024DA3AA8CQ35683181-B15C46AF-1E69-442F-9B25-0BDD13F271FCQ35804497-72C8BCF6-3BF1-4F29-A412-E6384C342043Q36227239-836FA679-68F9-49B0-A347-76ABAE98604FQ36294136-47751325-57DA-49AB-921D-F44705F749C6Q36489766-2C088450-D3F7-4CAA-B932-FDF6304DC40DQ36816444-3E756456-4F1C-42F1-AB8F-99357782F7D8Q37008599-E2BB9FEE-24E1-4679-B477-DBF12618DA67Q37061381-E4C22B9B-527F-4BA7-A0E6-4F0DD5122E2BQ37073022-8ED8E7C4-1FF2-4244-8D31-1F4563C2BF8CQ37076810-3B23C846-A93C-447D-BF5D-85A236A46EB2Q37636575-75C3C179-F751-4642-9E31-8954E29A0BE4Q37669224-4CF40F56-0DEC-404E-8C7B-BBFF0AAEAF76Q38082553-ADE6467A-5340-4272-9222-107F949BFA8AQ38134808-3A011947-DB3A-4A01-B2A7-F236D4F287FFQ38256873-A96F6A29-E1CD-4F17-9CC9-FBB7B9A926C1Q38319324-F9E49D29-BC4F-4921-92F9-4FC9080B77AEQ38444312-3E01EA03-84B3-4FB9-B66C-DF780C4D2042Q40108860-14945A2A-E4DE-407E-9D2A-18FC10EB14E7
P2860
Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Glypican-1 is a VEGF165 bindin ...... cellular chaperone for VEGF165
@ast
Glypican-1 is a VEGF165 bindin ...... cellular chaperone for VEGF165
@en
Glypican-1 is a VEGF165 bindin ...... cellular chaperone for VEGF165
@nl
type
label
Glypican-1 is a VEGF165 bindin ...... cellular chaperone for VEGF165
@ast
Glypican-1 is a VEGF165 bindin ...... cellular chaperone for VEGF165
@en
Glypican-1 is a VEGF165 bindin ...... cellular chaperone for VEGF165
@nl
prefLabel
Glypican-1 is a VEGF165 bindin ...... cellular chaperone for VEGF165
@ast
Glypican-1 is a VEGF165 bindin ...... cellular chaperone for VEGF165
@en
Glypican-1 is a VEGF165 bindin ...... cellular chaperone for VEGF165
@nl
P2093
P356
P1476
Glypican-1 is a VEGF165 bindin ...... cellular chaperone for VEGF165
@en
P2093
P304
P356
10.1074/JBC.274.16.10816
P407
P577
1999-04-16T00:00:00Z